Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenvatinib in Advanced Bone and Soft Tissue Sarcoma After Chemotherapy Failure
NCT05617859Phase 2Recruiting
- Sponsor
- Henan Cancer Hospital
- Start
- Apr 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenvatinib in bone sarcoma, soft tissue sarcoma (STS), sponsored by Henan Cancer Hospital. Started Apr 2023; status: recruiting.
02
Drugs
lenvatinib
03
Conditions
bone sarcomasoft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT05617859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05617859.